Nkgen Biotech Inc (NKGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,960 | 2,003 | -991 | 349 | -4,346 |
| Accounts payable and accrued liabilities | 79 | 26 | 52 | 35 | 17 |
| Other Working Capital | 1,223 | 452 | 982 | -253 | -939 |
| Other Operating Activity | -4,724 | -2,762 | -1,566 | -1,482 | 4,033 |
| Operating Cash Flow | $-462 | $-280 | $-1,524 | $-1,352 | $-1,235 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | N/A | N/A | -171,615 | -171,615 | -171,615 |
| Investing Cash Flow | $N/A | $N/A | $-171,615 | $-171,615 | $-171,615 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 1 | 1 | 1 |
| Debt Repayment | N/A | N/A | -70 | -70 | -70 |
| Other Financing Activity | 0 | 0 | 174,931 | 174,931 | 174,931 |
| Financing Cash Flow | $N/A | $N/A | $174,861 | $174,861 | $174,861 |
| Beginning Cash Position | 1,723 | 1,723 | N/A | N/A | N/A |
| End Cash Position | 1,260 | 1,443 | 1,723 | 1,894 | 2,012 |
| Net Cash Flow | $-462 | $-280 | $1,723 | $1,894 | $2,012 |
| Free Cash Flow | |||||
| Operating Cash Flow | -462 | -280 | -1,524 | -1,352 | -1,235 |
| Free Cash Flow | -462 | -280 | -1,524 | -1,352 | -1,235 |